Syndax Pharmaceuticals Inc (SNDX): Weighted Average Diluted Shares
86.63M
Year ended 2025-12-31
+12.5%
3-year compound annual growth
+16.0%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 86.63M | +1.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 85.62M | +21.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 70.37M | +15.8% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 60.76M | +13.3% | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | 53.62M | +29.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | 41.31M | +35.5% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | 30.49M | n/a | 2022-03-01, From 2019-01-01 |